Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 14 | 7 | 1 | — | 1 | 23 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 15 | 6 | 1 | — | — | 20 |
Triple negative breast neoplasms | D064726 | — | — | 6 | 4 | 1 | — | 3 | 14 |
Non-small-cell lung carcinoma | D002289 | — | — | 5 | 5 | 2 | — | — | 9 |
Glioblastoma | D005909 | EFO_0000515 | — | 1 | 3 | 1 | — | — | 3 |
Gliosarcoma | D018316 | — | — | 1 | 2 | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 14 | 3 | — | — | 4 | 21 |
Fallopian tube neoplasms | D005185 | — | — | 8 | 3 | — | — | — | 10 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 6 | 3 | — | — | — | 8 |
Astrocytoma | D001254 | EFO_0000271 | — | 3 | 2 | — | — | — | 4 |
Small cell lung carcinoma | D055752 | — | — | 3 | 3 | — | — | — | 4 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 3 | 1 | — | — | — | 3 |
Melanoma | D008545 | — | — | 2 | 1 | — | — | — | 3 |
Glioma | D005910 | EFO_0000520 | — | 2 | 2 | — | — | — | 3 |
Myelodysplastic syndromes | D009190 | — | D46 | 2 | 1 | — | — | — | 3 |
Myeloid leukemia acute | D015470 | — | C92.0 | 2 | 1 | — | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Stomach neoplasms | D013274 | EFO_0003897 | C16 | 4 | — | — | — | — | 4 |
Colonic neoplasms | D003110 | — | C18 | 4 | — | — | — | — | 4 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 4 | — | — | — | — | 4 |
Male breast neoplasms | D018567 | — | — | 3 | — | — | — | — | 3 |
Lymphoma | D008223 | — | C85.9 | 3 | — | — | — | — | 3 |
Endometrioid carcinoma | D018269 | — | — | 2 | — | — | — | — | 2 |
Hereditary breast and ovarian cancer syndrome | D061325 | — | — | 2 | — | — | — | — | 2 |
Medulloblastoma | D008527 | — | — | 2 | — | — | — | — | 2 |
Ependymoma | D004806 | — | — | 2 | — | — | — | — | 2 |
Primitive neuroectodermal tumors | D018242 | — | — | 2 | — | — | — | — | 2 |
Drug common name | Veliparib |
INN | veliparib |
Description | Veliparib is a benzimidazole substituted with a carbamoyl group at C-4 and a (2R)-2-methylpyrrolidin-2-yl moiety at C-2. It is a potent, orally bioavailable PARP inhibitor. It has a role as an EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor. |
Classification | Small molecule |
Drug class | poly-ADP-ribose polymerase inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C[C@]1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1 |
PDB | — |
CAS-ID | 912444-00-9 |
RxCUI | — |
ChEMBL ID | CHEMBL506871 |
ChEBI ID | 62880 |
PubChem CID | 11960529 |
DrugBank | DB07232 |
UNII ID | 01O4K0631N (ChemIDplus, GSRS) |